Medical Device Success

NOVEMBER 8, 2020

Reading time: 2 – 3 minutes Bob Iasillo, National Sales Director at 2020/Now, an emerging MedTech company needed actionable sales leads in this era where traditional prospecting tactics are no longer viable. He roled up his sleeves, did his research and put into action a unique social media campaign. No agency help.

Media 100

Media Leads Sales Doctors 100

Integrity Solutions

DECEMBER 21, 2020

For most of us, 2020 is a year we’ll be glad to see in the rear-view mirror. While disruption is always rough when you’re going through it, as 2020 closes out, we can also reflect back on some of the silver linings and positive developments that came out of the year.

Training 69

Training Sales Ethics Consulting 69

MedCity News

FEBRUARY 20, 2024

Sanofi, which is leading development of the Denali Therapeutics-partnered molecule, disclosed little about the clinical trial results in ALS. But this Phase 2 failure follows the 2020 clinical trial pause of a different partnered molecule that addresses the same target.

Leads 109

Leads Biopharma Pharma 109

Pharma Marketing Network

APRIL 27, 2021

HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. The post Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor appeared first on Pharma Marketing Network. Rod MacKenzie, PhD, is Chief Development Officer and Executive Vice President for Pfizer.

Medicine 52

Medicine Networking Safety Marketing 52

Medical Device Success

OCTOBER 18, 2020

Then in early 2020 Covid spread across the world. The post Episode 28 – A CEO Leading a MedTech Company Through Covid appeared first on Medical Device Success - Ideas You Can Put To Work Today! Then in early 2020 Covid spread across the world. But to take advantage of an opportunity, you have to execute.

Leads 100

Leads Doctors Competition Medical 100

pharmaphorum

OCTOBER 4, 2022

This week has seen two readouts for rivals from Clovis Oncology and Pfizer in prostate cancer – one of several indications on the Lynparza (olaparib) label – that could lead to a challenge to the $3 billion blockbuster. The post PARP rivals close in on AZ and Merck’s market leading Lynparza appeared first on.

Leads 52

Leads Marketing FDA Patients 52

World of DTC Marketing

JULY 9, 2021

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2

Pharma 292

Pharma FDA Leads Competition 292

Healthcare Success

MAY 9, 2022

In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. . consumers at the beginning of 2020, when the COVID-19 pandemic hit. 8 Ways to Improve the Patient Experience & Drive Leads with QR Codes. households.

Leads 112

Leads Patients Healthcare Provider Healthcare 112

World of DTC Marketing

JUNE 14, 2022

According to a new report , life expectancy in the United States took another hit in 2021, furthering a dramatic decline from 2020 that was the largest since World War II. years in 2020 and 76.60 In contrast, peer countries averaged a smaller decrease in life expectancy between 2019 and 2020 (0.57 years in 2019 to 76.99

Doctors 176

Doctors Insurance Healthcare Healthcare 176

Pharmaceutical Technology

NOVEMBER 21, 2022

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.

Marketing 69

Marketing Leads Pharmaceutical Manufacturing 69

Pharmaceutical Technology

AUGUST 11, 2022

In addition, according to the UK’s National Health Service’s (NHS) Delivering a ‘Net Zero’ National Health Service report from 2020, the HFCs used as propellant in inhalers account for 3-4% of the healthcare related carbon footprint in the UK. One dose from a DPI leads to only 4% of the emissions of a dose from a pMDI (Figure 1).

Leads 64

Leads Patients Pharma Marketing 64

Clarify Health

NOVEMBER 19, 2020

Leaders from Horizon BlueCross BlueShield of New Jersey, Abbvie, Kaweah Delta, and Clarify Health hosted a series of table talk discussions to unpack the concept of healthy data and to understand how leading organizations from [.].

Leads 40

Leads Healthcare Healthcare 40

Pharmaceutical Technology

NOVEMBER 21, 2022

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.

Leads 52

Leads Pharmaceutical Marketing Manufacturing 52

Healthcare Success

MAY 9, 2022

In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. . consumers at the beginning of 2020, when the COVID-19 pandemic hit. 8 Ways to Improve the Patient Experience & Drive Leads with QR Codes. households.

Leads 52

Leads Patients Healthcare Provider Healthcare 52

World of DTC Marketing

MARCH 17, 2021

Fierce Pharma just reported, “a big question hanging over AbbVie CEO Richard Gonzalez is whether he can lead the Illinois pharma safely through the patent cliff of its revenue cornerstone Humira. By the look of 2020’s results, he’s on the right track—and his compensation shows it.

Pharma 186

Pharma Competition Prescription Doctors 186

World of DTC Marketing

NOVEMBER 18, 2021

prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 leading to an almost $1.4 leading to an almost $1.4 Using pricing data from 2019 and 2020, ICER pegged Humira’s net price increase at 9.6% According to Reuters “drugmakers hiked U.S.

Pharma 202

Pharma Prescription Medicine Manufacturing 202

Pharmaceutical Technology

JUNE 30, 2022

In 2020, there was an increase in foreign aid funding , which was attributed to Covid-19 related efforts in developing countries. The post Neglected tropical diseases: non-profits lead the way as private sectors lags appeared first on Pharmaceutical Technology.

Leads 64

Leads Pharma Medicine FDA 64

Pharmaceutical Technology

APRIL 4, 2023

The FDA has seen a record surge in review designations being awarded over the last two years for Alzheimer’s indications, with 12 review designations being awarded to drugs between 2020 and 2022. Between 2020 and 2021, the number of designations increased by 600%, with seven designations being awarded by the FDA in 2021. ©GlobalData.

FDA 98

FDA Specialization Leads Marketing 98

World of DTC Marketing

JANUARY 12, 2022

bil­lion in 2020, ac­cord­ing to In­flu­encer Mar­ket­ing Hub , which es­ti­mat­ed the mar­ket would grow to $13.8 At the same time, over­all dig­i­tal ad spend in the phar­ma space sky­rock­et­ed 242% year over year from Jan­u­ary to Feb­ru­ary in 2020 and 2021, Me­di­aRadar re­port­ed. bil­lion in 2021.

Marketing 192

Marketing Pharma Side effects Media 192

World of DTC Marketing

MARCH 6, 2022

Global consumers will spend $49 billion by 2020 on digital health solutions. Policymakers may address two areas to foster such an environment: clarifying the regulatory requirements for such technologies and developing incentives that lead to a more robust customer market. Maybe, however, they should check with patients first.

Patients 244

Patients Doctors Leads FDA 244

World of DTC Marketing

AUGUST 14, 2022

According to Healthcare Transformers, “ use of telehealth climbed more than 154% in late March 2020, compared with the year before, and a 2020 survey found 76% of patients would be interested in using it. They are central aspects of the physical examination, leading to accurate diagnoses and treatment. There it is again.

Doctors 154

Doctors Physicians Healthcare Healthcare 154

Pharma Marketing Network

JULY 19, 2023

For example, Pfizer, a leading pharmaceutical company, has a long history of sponsoring research into new drugs and treatments. In 2020, the company committed to investing $5 billion in research and development over the next five years. This could help to improve the lives of patients and make a real difference in the world.

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98

World of DTC Marketing

DECEMBER 30, 2021

Data show a roughly 46 percent combined decrease in weekly new diagnoses across six different cancers, according to a study published in August 2020 in JAMA Network Open. If the downward trend in screenings and treatments continues, it will lead to a public health catastrophe.

Networking 187

Networking Physicians Education Patients 187

Pharmaceutical Technology

MARCH 8, 2023

Lilly launched a rapid insulin lispro, Lyumjev, in 2020, which has a lower price than Humalog at about $300 for 10ml (100 units/ml) and has underlined Lilly’s dominance in the insulin lispro market. At $92 for a five-pack of injections, Rezvoglar is a 78% discount on the price of Lantus.

Competition 105

Competition Insurance Leads Marketing 105

Pharmaceutical Technology

MAY 9, 2023

GlobalData’s Cybersecurity in Healthcare – Thematic Research market report helps get a detailed understanding on how Cybersecurity impacts the value chain in the pharmaceutical sector, and the leading Cybersecurity adopters and vendors in the market. Starting at 100 in 2020, an index over 100 is more positive.

Pharmaceutical 81

Pharmaceutical Healthcare Healthcare Leads 81

Pharma Pathway

MARCH 13, 2023

Divis Laboratories- Walk-In Freshers -B.Sc/ M.Sc/ M.Pharm/ B.Pharm/ B.Tech On 15th to 18th March 2023 Job Description Divis is the leading manufacturer of APIs (Active Pharmaceuticals Ingredients ), Intermediates and Registered starting materials offering high quality products with the highest level of compliance and integrity to over 95 Countries.

Manufacturing 81

Manufacturing Leads Pharmaceutical Pharma 81

Pharma Marketing Network

JANUARY 27, 2021

2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. Some Key Discussion Topics Include: What have we learned about how to create connection within this new paradigm? Which recent innovations are poised to become the best practices that will create measurable impact in 2021?

Networking 98

Networking Pharma Marketing Leads 98

PharmExec

SEPTEMBER 12, 2022

According to a survey conducted by Florence Healthcare, 47% of research sites had adopted eConsent by December 2020, just 8 months after the WHO declared an official pandemic. Learn why Medable's Total eConsent offering is the industry-leading remote consent technology, and how it can reduce your enrolment timelines by 50%.

Patients 52

Patients Healthcare Healthcare Leads 52

Pharmaceutical Technology

MAY 9, 2023

GlobalData’s Cybersecurity in Healthcare – Thematic Research market report helps get a detailed understanding on how Cybersecurity impacts the value chain in the pharmaceutical sector, and the leading Cybersecurity adopters and vendors in the market. Starting at 100 in 2020, an index over 100 is more positive.

Pharmaceutical 75

Pharmaceutical Healthcare Healthcare Leads 75

European Pharmaceutical Review

MARCH 9, 2023

We discovered a way to shut down inflammation… in a patient with multiple sclerosis as well as in healthy patients,” stated lead author Thais Moreira, PhD, an assistant scientist at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital and an instructor in Neurology at Harvard Medical School.

Side effects 145

Side effects Patients Leads Medical 145

World of DTC Marketing

FEBRUARY 1, 2022

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. According to EY, there were 69 deals worth $128 billion in 2020 and 90 deals worth $108 billion in 2021.

Food and Drug Administration 234

Food and Drug Administration FDA Pharmaceutical Food 234

Pharma Pathway

FEBRUARY 26, 2023

HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Pharmaceutical 85

Pharmaceutical Manufacturing Leads Pharma 85

Pharma Pathway

FEBRUARY 14, 2023

HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Engineering 84

Engineering Pharmaceutical Manufacturing Leads 84

World of DTC Marketing

FEBRUARY 1, 2021

SUMMARY: Digital ad spend in pharmaceutical brands is up 111% so far in 2020 and 80% of that money is being thrown away by fraud and the popularity of programmatic advertising. Managers and digital agencies have to take a lot of the blame for boring online ads and lack of creativity that could actually lead to better metrics.

Pharma 187

Pharma Media Pharmaceutical Management 187

Pharma Pathway

DECEMBER 13, 2022

HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Pass out year: 2019/ 2020/2021/ 2022. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics. Departments: QA/ QC.

Pharmaceutical 80

Pharmaceutical Manufacturing Leads Pharma 80

Pharmaceutical Technology

JUNE 12, 2023

It includes market sizing analysis and the leading Cloud adopters and vendors in the market. Of the top leading companies in the pharmaceutical industry, Pfizer had the greatest increase in references for cloud in Q1 2023, compared with the previous quarter. Starting at 100 in 2020, an index over 100 is more positive.

Pharmaceutical 52

Pharmaceutical Healthcare Healthcare Leads 52

Pharma Pathway

FEBRUARY 20, 2023

HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Pharmaceutical 78

Pharmaceutical Manufacturing Leads Pharma 78